TSS
BIO icon

Two Sigma Securities’s Bio-Rad Laboratories Class A BIO Stock Holding History

Two Sigma Securities’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,400
Closed -$484K – 2989
2024
Q1 		$484K Sell
1,400
-1,700
-55% -$559K ﹤0.01% 1606
2023
Q4 		$1M Buy
+3,100
New +$972K 0.01% 1041
2022
Q3 		– Sell
-800
Closed -$396K – 2612
2022
Q2 		$396K Buy
+800
New +$417K 0.01% 1072

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Two Sigma Securities's BIO Position: Q1 2026 in Review

Two Sigma Securities sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2026, closing a stake of 1,199 shares — an estimated $363K sold.

Two Sigma Securities first reported a position in BIO in Q3 2022 and held it in 4 quarters. The position peaked at $920K in Q3 2022. 391 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Two Sigma Securities reported no remaining Bio-Rad Laboratories Class A position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 1,199 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $363K.
  • Two Sigma Securities first reported a position in Bio-Rad Laboratories Class A in Q3 2022 and held it in 4 quarters.
  • Two Sigma Securities's Bio-Rad Laboratories Class A position peaked at $920K in Q3 2022.
  • 391 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.